troublesome and fibrillation may afford an additional layer of protection and allow more effective deairing in some cases. Additional benefits from fibrillating the heart during pump exchange are reduced blood loss from the apical inflow site during pump exchange and decreased risk of blood contact contamination of the operating team from an ejecting left ventricle. Because most patients with an LVAD also have an AICD in situ, we suggest that the method described here is a simple means to induce, maintain, and reverse fibrillation. Although dissecting out the base of the right ventricle to attach a fibrillator lead is also possible, this adds another layer of complexity to the surgery with increased risk of bleeding and injury to the heart, and risks unanticipated cardiac ejection if wires are displaced and the heart beats spontaneously. By using the AICD to fibrillate, we were able to keep the procedure almost entirely within the LVAD pocket, making it truly minimally invasive. Furthermore, as seen in our case, defibrillation by external pads may be difficult.
The potential applications of this approach are not limited to LVAD device exchange, but could be extended to other minimal access cardiac surgical procedures in patients who have AICDs. The approach may be useful in such procedures, particularly where access to the heart is limited, or where there is a desire to avoid aortic clamping, such as mitral valve repair via thoracotomy in a patient with previous coronary bypass grafts and depressed ventricular function. Cardiac hemangioma at the apex of the right ventricle: A case report and literature review
Wen-Jian Jiang, MD, Jin-Hua Li, MD, Jiang Dai, MD, and Yong-Qiang Lai, MD, Beijing, China
Primary tumors and cysts of the heart and pericardium are rare, and only 2.8% of these tumors are cardiac hemangiomas. 1 Ventricular hemangiomas are extremely uncommon. We report one of these unusual cases and discuss others in the literature.
CLINICAL SUMMARY
A 49-year-old man without symptoms was admitted to our hospital. A mass between the right ventricle (RV) and the pericardium was demonstrated on his chest computed tomography (Figure 1, A) . Transthoracic echocardiography showed the mass to be located at the apex of the RV, and there was no hemodynamic abnormality or RVoutflow tract obstruction.
The mass adjacent to the RV had a clear border with the normal myocardium (Figure 1, B) . It was totally excised under cardiopulmonary bypass. A patch of autologous pericardium covered with Dacron polyester fabric was used for the reconstruction of the RV (Figure 1, C) . This patient recovered uneventfully, with no evidence of recurrence after 6 months of follow-up. The size of the mass was 6.8 3 5.0 3 2.6 cm (Figure 1, D) . Histologic diagnosis was hemangioma (Figure 1, E) .
DISCUSSION
Primary tumors and cysts of the heart and pericardium are rare, and only 2.8% of these tumors are cardiac hemangiomas. 1 Hemangiomas of the heart affect all ages and may occur anywhere within the heart, 2 but ventricular hemangiomas are extremely uncommon. In 45 reviewed cases of cardiac hemangioma, only 11 were located in the RV. 3 Cardiac hemangiomas are vascular tumors composed of capillaries or cavernous vascular channels, and most are benign. 4 Surgery is the first choice of therapy in all patients with cardiac tumors. 5 To date, 30 cases of hemangiomas located in the RV (including that reported here) have been reported in the literature. Table 1 shows the summary of preoperative data and lists the surgical procedures in these cases. The most common sites were the anterior wall of the RV in 20 patients (66.7%), including the apex of the RV in 2 patients and the RV outflow tract in 10 others (33.3%). Sotoda and colleagues 6 reported the first cardiac hemangioma at the apex of the RV in 2008, and our case is the second ever reported.
All 30 patients described in the literature underwent operation. Cardiopulmonary bypass was used in 76.7% of the cases. Total resection of the tumor was done in 83.3% of cases, 88% with cardiopulmonary bypass. Surgical outcome and follow-up information were available for 23 patients, who were followed up for periods ranging between 6 months and 2 years; all were alive and well at follow-up. Especially for the cardiac hemangiomas located in the anterior wall of the RV, the reconstruction of cardiac ventricle after the resection of the tumor, which is the same as the procedure after the resection of ventricular aneurysmectomy, is important, because heart failure can result from low cardiac output. 5 Because of the reconstruction of the RV, postoperatively cardiac function in our case was satisfactory.
Considering all the points discussed here, we may safely conclude that most cardiac hemangiomas in the RV are located in the anterior wall, and these patients should undergo reconstruction of the ventricle after resection of the tumor under CPB. Long-term outcome seems satisfactory, and little recurrence has been reported. The development of artificial heart valves has revolutionized cardiac surgery. During the past 60 years, heart valve prostheses have evolved considerably, with each new model designed with the hope of better hemodynamics and outcomes for patients. The Cooley-Cutter heart valve was designed in the 1960s by Denton A. Cooley, MD, in collaboration with Cutter Laboratories and introduced for clinical use in 1971. 1 The device used 2 sets of titanium struts to contain a biconic occluder composed of pyrolytic carbon. Cooley-Cutter heart valves were used frequently in the 1970s, 2 with Dr Cooley alone having implanted the device in a total of 3275 patients (1786 in the aortic position and 1475 in the mitral) over a 10-year period, with very good clinical results. 3 Since that time, newer mechanical valves have replaced the Cooley-Cutter valve.
CLINICAL SUMMARY
An 85-year-old man with a medical history significant for diabetes, coronary artery disease, previous stent placement in the left anterior descending coronary artery, and previous mechanical aortic valve replacement was seen for dyspnea on exertion and minor weight loss. The patient's surgical history was significant for aortic valve replacement with a Cooley-Cutter prosthesis, implanted by Dr Cooley at the Texas Heart Institute on October 4, 1973. Results of physical examination were unremarkable; cardiac examination revealed regular rate and rhythm with S1 and S2, no S3 or S4, and no appreciable murmurs, rubs, or gallops.
Transthoracic echocardiography (Figure 1 ) showed an intact aortic valve replacement. The valve was properly seated with normal occluder motion. The peak transvalvular velocity was 3.4 m/s, with a mean gradient of 24 mm Hg. The left ventricular ejection fraction was calculated to be 60%.
DISCUSSION
A recent single-center retrospective review of the results of the use of the St Jude mechanical valve 4 demonstrated a 25-year survival of 17% AE 4%. In the context of these results, it is high unusual to document such excellent functional results as those of this 40-year-old Cooley-Cutter prosthesis. Another mechanical aortic valve prosthesis that has been shown to be remarkably durable in certain cases is the Starr-Edwards prosthesis. 5 Our patient's symptoms were ultimately found to be unrelated to his cardiac history, and he currently remains well controlled on warfarin. Overall, the prosthetic valve remains in excellent condition with no need for replacement. 
